Nicholas Company’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79.6M | Sell |
1,139,599
-21,410
| -2% | -$1.5M | 1.33% | 13 |
|
|
2025
Q1 | $85.3M | Hold |
1,161,009
| – | – | 1.48% | 12 |
|
|
2024
Q4 | $76.1M | Buy |
1,161,009
+171,199
| +17% | +$11.2M | 1.23% | 20 |
|
|
2024
Q3 | $77.1M | Sell |
989,810
-5,815
| -0.6% | -$453K | 1.25% | 24 |
|
|
2024
Q2 | $77.6M | Hold |
995,625
| – | – | 1.29% | 13 |
|
|
2024
Q1 | $67.5M | Buy |
995,625
+168,000
| +20% | +$11.4M | 1.11% | 30 |
|
|
2023
Q4 | $55.7M | Buy |
827,625
+707,215
| +587% | +$47.6M | 0.99% | 41 |
|
|
2023
Q3 | $8.15M | Sell |
120,410
-525
| -0.4% | -$35.6K | 0.16% | 123 |
|
|
2023
Q2 | $8.66M | Hold |
120,935
| – | – | 0.17% | 123 |
|
|
2023
Q1 | $8.39M | Buy |
120,935
+65
| +0.1% | +$4.51K | 0.17% | 131 |
|
|
2022
Q4 | $8.19M | Buy |
120,870
+5,000
| +4% | +$339K | 0.18% | 134 |
|
|
2022
Q3 | $6.35M | Buy |
115,870
+45,340
| +64% | +$2.49M | 0.15% | 156 |
|
|
2022
Q2 | $4.66M | Hold |
70,530
| – | – | 0.1% | 207 |
|
|
2022
Q1 | $4.68M | Buy |
+70,530
| New | +$4.68M | 0.08% | 215 |
|